Testing new treatments for infectious diseases.
Early Phase Clinical Trial Unit
This study is looking for people to help test new treatments for infectious diseases, so if you're interested, you could join in and help find better ways to fight these illnesses!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10697192 on NIH RePORTER |
What this research studies
This research focuses on early phase clinical trials aimed at investigating new agents for the treatment and prevention of infectious diseases. Patients may have the opportunity to participate in trials that evaluate the effectiveness and safety of innovative therapies. The approach involves comprehensive clinical trial implementation, which includes recruiting participants, administering treatments, and monitoring outcomes. By participating, patients can contribute to the development of new interventions that may improve health outcomes for those affected by infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with infectious diseases who are seeking new treatment options.
Not a fit: Patients with non-infectious diseases or those who do not meet the eligibility criteria for the trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have performed: Other research in early phase clinical trials has shown success in developing new treatments for infectious diseases, indicating that this approach is both tested and promising.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Guptill, Jeffrey — Duke University
- Study coordinator: Guptill, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.